Thomas W. Geisbert, Ph.D. - Publications

Affiliations: 
2003 Uniformed Services University of the Health Sciences, Bethesda, MD 
Area:
Animal Pathology Agriculture, Microbiology Biology, Pathology

248 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Cross RW, Woolsey C, Prasad AN, Borisevich V, Agans KN, Deer DJ, Geisbert JB, Dobias NS, Fenton KA, Geisbert TW. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever. Cell Reports. 40: 111094. PMID 35858566 DOI: 10.1016/j.celrep.2022.111094  0.373
2022 Woolsey C, Fears AC, Borisevich V, Agans KN, Dobias NS, Prasad AN, Deer DJ, Geisbert JB, Fenton KA, Geisbert TW, Cross RW. Natural history of infection in rhesus and cynomolgus macaques. Emerging Microbes & Infections. 1-306. PMID 35657325 DOI: 10.1080/22221751.2022.2086072  0.448
2022 Woolsey C, Cross RW, Agans KN, Borisevich V, Deer DJ, Geisbert JB, Gerardi C, Latham TE, Fenton KA, Egan MA, Eldridge JH, Geisbert TW, Matassov D. A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge. Plos Neglected Tropical Diseases. 16: e0010433. PMID 35622847 DOI: 10.1371/journal.pntd.0010433  0.453
2022 Cross RW, Bornholdt ZA, Prasad AN, Woolsey C, Borisevich V, Agans KN, Deer DJ, Abelson DM, Kim DH, Shestowsky WS, Campbell LA, Bunyan E, Geisbert JB, Dobias NS, Fenton KA, ... ... Geisbert TW, et al. Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease. Jci Insight. PMID 35413016 DOI: 10.1172/jci.insight.159090  0.382
2022 Milligan JC, Davis CW, Yu X, Ilinykh PA, Huang K, Halfmann PJ, Cross RW, Borisevich V, Agans KN, Geisbert JB, Chennareddy C, Goff AJ, Piper AE, Hui S, Shaffer KCL, ... ... Geisbert TW, et al. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses. Cell. 185: 995-1007.e18. PMID 35303429 DOI: 10.1016/j.cell.2022.02.023  0.324
2022 Foster SL, Woolsey C, Borisevich V, Agans KN, Prasad AN, Deer DJ, Geisbert JB, Dobias NS, Fenton KA, Cross RW, Geisbert TW. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease. Proceedings of the National Academy of Sciences of the United States of America. 119: e2200065119. PMID 35286211 DOI: 10.1073/pnas.2200065119  0.376
2021 Woolsey C, Geisbert TW. Current state of Ebola virus vaccines: A snapshot. Plos Pathogens. 17: e1010078. PMID 34882741 DOI: 10.1371/journal.ppat.1010078  0.331
2021 Royal JM, Simpson CA, McCormick AA, Phillips A, Hume S, Morton J, Shepherd J, Oh Y, Swope K, DeBeauchamp JL, Webby RJ, Cross RW, Borisevich V, Geisbert TW, Demarco JK, et al. Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle. Vaccines. 9. PMID 34835278 DOI: 10.3390/vaccines9111347  0.319
2021 Gilchuk P, Murin CD, Cross RW, Ilinykh PA, Huang K, Kuzmina N, Borisevich V, Agans KN, Geisbert JB, Zost SJ, Nargi RS, Sutton RE, Suryadevara N, Bombardi RG, Carnahan RH, ... ... Geisbert TW, et al. Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 184: 5593-5607.e18. PMID 34715022 DOI: 10.1016/j.cell.2021.09.035  0.317
2021 Lehrer AT, Chuang E, Namekar M, Williams CA, Wong TAS, Lieberman MM, Granados A, Misamore J, Yalley-Ogunro J, Andersen H, Geisbert JB, Agans KN, Cross RW, Geisbert TW. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses. Frontiers in Immunology. 12: 703986. PMID 34484200 DOI: 10.3389/fimmu.2021.703986  0.383
2021 Doyle MP, Kose N, Borisevich V, Binshtein E, Amaya M, Nagel M, Annand EJ, Armstrong E, Bombardi R, Dong J, Schey KL, Broder CC, Zeitlin L, Kuang EA, Bornholdt ZA, ... ... Geisbert TW, et al. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein. Cell Reports. 36: 109628. PMID 34469726 DOI: 10.1016/j.celrep.2021.109628  0.373
2021 Sorvillo TE, Cross RW, Johnson DM, Dobias NS, Fenton KA, Mire CE, Geisbert TW. Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge. Npj Vaccines. 6: 96. PMID 34373461 DOI: 10.1038/s41541-021-00361-0  0.385
2021 Woolsey C, Borisevich V, Agans KN, Fenton KA, Cross RW, Geisbert TW. Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling. Mbio. e0151721. PMID 34372693 DOI: 10.1128/mBio.01517-21  0.402
2021 Amaya M, Cheng H, Borisevich V, Navaratnarajah CK, Cattaneo R, Cooper L, Moore TW, Gaisina IN, Geisbert TW, Rong L, Broder CC. A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Research. 105084. PMID 34077807 DOI: 10.1016/j.antiviral.2021.105084  0.363
2021 Fels JM, Maurer DP, Herbert AS, Wirchnianski AS, Vergnolle O, Cross RW, Abelson DM, Moyer CL, Mishra AK, Aguilan JT, Kuehne AI, Pauli NT, Bakken RR, Nyakatura EK, Hellert J, ... ... Geisbert TW, et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell. PMID 34077751 DOI: 10.1016/j.cell.2021.05.001  0.39
2021 Dang HV, Cross RW, Borisevich V, Bornholdt ZA, West BR, Chan YP, Mire CE, Da Silva SC, Dimitrov AS, Yan L, Amaya M, Navaratnarajah CK, Zeitlin L, Geisbert TW, Broder CC, et al. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Nature Structural & Molecular Biology. PMID 33927387 DOI: 10.1038/s41594-021-00584-8  0.35
2021 Zeitlin L, Cross RW, Geisbert JB, Borisevich V, Agans KN, Prasad AN, Enterlein S, Aman MJ, Bornholdt ZA, Brennan MB, Campbell L, Kim D, Mlakar N, Moyer CL, Pauly MH, ... ... Geisbert TW, et al. Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33836604 DOI: 10.1073/pnas.2023332118  0.368
2021 Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, Wiethoff CM, Blackbourne JL, Heinz BA, Foster D, Higgs RE, Balasubramaniam D, Wang L, Zhang Y, Yang ES, ... ... Geisbert TW, et al. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in non-human primates. Science Translational Medicine. PMID 33820835 DOI: 10.1126/scitranslmed.abf1906  0.343
2021 Cross RW, Bornholdt ZA, Prasad AN, Borisevich V, Agans KN, Deer DJ, Abelson DM, Kim DH, Shestowsky WS, Campbell LA, Bunyan E, Geisbert JB, Fenton KA, Zeitlin L, Porter DP, ... Geisbert TW, et al. Combination therapy protects macaques against advanced Marburg virus disease. Nature Communications. 12: 1891. PMID 33767178 DOI: 10.1038/s41467-021-22132-0  0.407
2021 Cross RW, Prasad AN, Borisevich V, Woolsey C, Agans KN, Deer DJ, Dobias NS, Geisbert JB, Fenton KA, Geisbert TW. Use of convalescent serum reduces severity of COVID-19 in nonhuman primates. Cell Reports. 108837. PMID 33662255 DOI: 10.1016/j.celrep.2021.108837  0.321
2021 Geisbert TW, Bobb K, Borisevich V, Geisbert JB, Agans KN, Cross RW, Prasad AN, Fenton KA, Yu H, Fouts TR, Broder CC, Dimitrov AS. A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus. Npj Vaccines. 6: 23. PMID 33558494 DOI: 10.1038/s41541-021-00284-w  0.382
2021 Wang Y, Howell KA, Brannan J, Agans KN, Turner HL, Wirchnianski AS, Kailasan S, Fusco M, Galkin A, Chiang CI, Zhao X, Saphire EO, Chandran K, Ward AB, Dye JM, ... ... Geisbert TW, et al. Prominent Neutralizing Antibody Response Targeting the Glycoprotein Subunit Interface Elicited by Immunization. Journal of Virology. PMID 33536172 DOI: 10.1128/JVI.01907-20  0.347
2021 Pinski A, Woolsey C, Jankeel A, Cross R, Basler CF, Geisbert T, Messaoudi I. Transcriptional analysis of lymphoid tissues from infected nonhuman primates reveals the basis for attenuation and immunogenicity of an Ebola virus encoding a mutant VP35 protein. Journal of Virology. PMID 33408171 DOI: 10.1128/JVI.01995-20  0.362
2020 Dong J, Cross RW, Doyle MP, Kose N, Mousa JJ, Annand EJ, Borisevich V, Agans KN, Sutton R, Nargi R, Majedi M, Fenton KA, Reichard W, Bombardi RG, Geisbert TW, et al. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Cell. 183: 1536-1550.e17. PMID 33306954 DOI: 10.1016/j.cell.2020.11.023  0.362
2020 Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, Heymann JC, Foster SL, Levine CB, Medina L, Melody K, Geisbert JB, Fenton KA, Geisbert TW, Cross RW. Establishment of an African green monkey model for COVID-19 and protection against re-infection. Nature Immunology. PMID 33235385 DOI: 10.1038/s41590-020-00835-8  0.354
2020 Heinrich ML, Boisen ML, Nelson DKS, Bush DJ, Cross RW, Koval AP, Hoffmann AR, Beddingfield BJ, Hastie KM, Rowland MM, Aimukanova I, Koval S, Lathigra R, Borisevich V, Momoh M, ... ... Geisbert TW, et al. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages. Scientific Reports. 10: 16030. PMID 32994446 DOI: 10.1038/s41598-020-72539-w  0.312
2020 Cross RW, Agans KN, Prasad AN, Borisevich V, Woolsey C, Deer DJ, Dobias NS, Geisbert JB, Fenton KA, Geisbert TW. Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase. Virology Journal. 17: 125. PMID 32811514 DOI: 10.1186/S12985-020-01396-W  0.4
2020 Cross RW, Prasad AN, Borisevich V, Geisbert JB, Agans KN, Deer DJ, Fenton KA, Geisbert TW. Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys. Plos Neglected Tropical Diseases. 14: e0008637. PMID 32790668 DOI: 10.1371/Journal.Pntd.0008637  0.484
2020 Cross RW, Bornholdt ZA, Prasad AN, Geisbert JB, Borisevich V, Agans KN, Deer DJ, Melody K, Fenton KA, Feldmann H, Sprecher A, Zeitlin L, Geisbert TW. Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment. Nature Communications. 11: 3736. PMID 32719371 DOI: 10.1038/S41467-020-17446-4  0.457
2020 Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, Heymann JC, Foster SL, Levine CB, Medina L, Melody K, Geisbert JB, Fenton KA, Geisbert TW, Cross RW. Establishment of an African green monkey model for COVID-19. Biorxiv : the Preprint Server For Biology. PMID 32511377 DOI: 10.1101/2020.05.17.100289  0.405
2020 Feldmann H, Sprecher A, Geisbert TW. Ebola. The New England Journal of Medicine. 382: 1832-1842. PMID 32441897 DOI: 10.1056/NEJMra1901594  0.317
2020 Satterfield BA, Cross RW, Fenton KA, Borisevich V, Agans KN, Deer DJ, Graber J, Basler CF, Geisbert TW, Mire CE. Correction for Satterfield et al., "Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets". Journal of Virology. 94. PMID 32234799 DOI: 10.1128/Jvi.00059-20  0.342
2020 Jankeel A, Menicucci AR, Woolsey C, Fenton KA, Mendoza N, Versteeg K, Cross RW, Geisbert TW, Messaoudi I. Early transcriptional changes within liver, adrenal gland and lymphoid tissues significantly contribute to Ebola pathogenesis in cynomolgus macaques. Journal of Virology. PMID 32213610 DOI: 10.1128/Jvi.00250-20  0.417
2020 Woolsey C, Jankeel A, Matassov D, Geisbert JB, Agans KN, Borisevich V, Cross RW, Deer DJ, Fenton KA, Latham TE, Gerardi CS, Mire CE, Eldridge JH, Messaoudi I, Geisbert TW. Immune correlates of postexposure vaccine protection against Marburg virus. Scientific Reports. 10: 3071. PMID 32080323 DOI: 10.1038/S41598-020-59976-3  0.486
2020 Gilchuk P, Murin CD, Milligan JC, Cross RW, Mire CE, Ilinykh PA, Huang K, Kuzmina N, Altman PX, Hui S, Gunn BM, Bryan AL, Davidson E, Doranz BJ, Turner HL, ... ... Geisbert TW, et al. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization. Immunity. PMID 32023489 DOI: 10.1016/J.Immuni.2020.01.001  0.417
2020 Mishra AK, Moyer CL, Abelson DM, Deer DJ, El Omari K, Duman R, Lobel L, Lutwama JJ, Dye JM, Wagner A, Chandran K, Cross RW, Geisbert TW, Zeitlin L, Bornholdt ZA, et al. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38. Journal of Virology. PMID 31996434 DOI: 10.1128/Jvi.02005-19  0.47
2020 Cohen-Dvashi H, Amon R, Agans KN, Cross RW, Borenstein-Katz A, Mateo M, Baize S, Padler-Karavani V, Geisbert TW, Diskin R. Rational design of universal immunotherapy for TfR1-tropic arenaviruses. Nature Communications. 11: 67. PMID 31900422 DOI: 10.1038/S41467-019-13924-6  0.419
2020 Fels JM, Maurer D, Kuehne AI, Abelson DM, Pauli NT, Herbert AS, Dye JM, Cross RW, Geisbert TW, Lobel L, Bornholdt ZA, Walker LM, Chandran K. Neutralizing Antibodies against Crimean–Congo Hemorrhagic Fever Virus Derived from a Human Survivor Proceedings. 50: 128. DOI: 10.3390/proceedings2020050128  0.435
2019 Prasad AN, Woolsey C, Geisbert JB, Agans KN, Borisevich V, Deer DJ, Mire CE, Cross RW, Fenton KA, Broder CC, Geisbert TW. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity. The Journal of Infectious Diseases. PMID 32022850 DOI: 10.1093/Infdis/Jiz613  0.53
2019 Cross RW, Xu R, Matassov D, Hamm S, Latham TE, Gerardi CS, Nowak RM, Geisbert JB, Ota-Setlik A, Agans KN, Luckay A, Witko SE, Soukieh L, Deer DJ, Mire CE, ... ... Geisbert TW, et al. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death. The Journal of Clinical Investigation. PMID 31820871 DOI: 10.1172/Jci131958  0.476
2019 Satterfield BA, Borisevich V, Foster SL, Rodriguez SE, Cross RW, Fenton KA, Agans KN, Basler CF, Geisbert TW, Mire CE. Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model. Scientific Reports. 9: 16710. PMID 31723221 DOI: 10.1038/S41598-019-53037-0  0.335
2019 Mire CE, Chan YP, Borisevich V, Cross RW, Yan L, Agans KN, Dang HV, Veesler D, Fenton KA, Geisbert TW, Broder CC. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. The Journal of Infectious Diseases. PMID 31686101 DOI: 10.1093/Infdis/Jiz515  0.535
2019 Geisbert JB, Borisevich V, Prasad AN, Agans KN, Foster SL, Deer DJ, Cross RW, Mire CE, Geisbert TW, Fenton KA. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys. The Journal of Infectious Diseases. PMID 31665362 DOI: 10.1093/Infdis/Jiz391  0.485
2019 Prasad AN, Agans KN, Sivasubramani SK, Geisbert JB, Borisevich V, Mire CE, Lawrence WS, Fenton KA, Geisbert TW. A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys. The Journal of Infectious Diseases. PMID 31665351 DOI: 10.1093/Infdis/Jiz469  0.463
2019 Dang HV, Chan YP, Park YJ, Snijder J, Da Silva SC, Vu B, Yan L, Feng YR, Rockx B, Geisbert TW, Mire CE, Broder CC, Veesler D. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. Nature Structural & Molecular Biology. PMID 31570878 DOI: 10.1038/S41594-019-0308-9  0.477
2019 Woolsey C, Menicucci AR, Cross RW, Luthra P, Agans KN, Borisevich V, Geisbert JB, Mire CE, Fenton KA, Jankeel A, Anand S, Ebihara H, Geisbert TW, Messaoudi I, Basler CF. A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge. Cell Reports. 28: 3032-3046.e6. PMID 31533029 DOI: 10.1016/J.Celrep.2019.08.047  0.457
2019 Jasenosky LD, Cadena C, Mire CE, Borisevich V, Haridas V, Ranjbar S, Nambu A, Bavari S, Soloveva V, Sadukhan S, Cassell GH, Geisbert TW, Hur S, Goldfeld AE. The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus. Iscience. PMID 31402258 DOI: 10.1016/J.Isci.2019.07.003  0.456
2019 Cross RW, Hastie KM, Mire CE, Robinson JE, Geisbert TW, Branco LM, Ollmann Saphire E, Garry RF. Antibody therapy for Lassa fever. Current Opinion in Virology. 37: 97-104. PMID 31401518 DOI: 10.1016/J.Coviro.2019.07.003  0.408
2019 Hastie KM, Cross RW, Harkins SS, Zandonatti MA, Koval AP, Heinrich ML, Rowland MM, Robinson JE, Geisbert TW, Garry RF, Branco LM, Saphire EO. Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization. Cell. 178: 1004-1015.e14. PMID 31398326 DOI: 10.1016/J.Cell.2019.07.020  0.356
2019 Rodriguez SE, Cross RW, Fenton KA, Bente DA, Mire CE, Geisbert TW. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever. Scientific Reports. 9: 7755. PMID 31123310 DOI: 10.1038/S41598-019-44210-6  0.53
2019 Mire CE, Geisbert JB, Agans KN, Versteeg KM, Deer DJ, Satterfield BA, Fenton KA, Geisbert TW. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease. Emerging Infectious Diseases. 25: 1144-1152. PMID 31107231 DOI: 10.3201/Eid2506.181620  0.515
2019 Versteeg K, Menicucci AR, Woolsey C, Mire CE, Geisbert JB, Cross RW, Agans KN, Jeske D, Messaoudi I, Geisbert TW. Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants. Scientific Reports. 9: 7329. PMID 31065012 DOI: 10.1038/S41598-019-42949-6  0.397
2019 Bornholdt ZA, Herbert AS, Mire CE, He S, Cross RW, Wec AZ, Abelson DM, Geisbert JB, James RM, Rahim MN, Zhu W, Borisevich V, Banadyga L, Gunn BM, Agans KN, ... ... Geisbert TW, et al. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. Cell Host & Microbe. 25: 49-58.e5. PMID 30629918 DOI: 10.1016/J.Chom.2018.12.005  0.58
2018 Cross RW, Speranza E, Borisevich V, Widen SG, Wood TG, Shim RS, Adams RD, Gerhardt DM, Bennett RS, Honko AN, Johnson JC, Hensley LE, Geisbert TW, Connor JH. Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans. The Journal of Infectious Diseases. 218: S486-S495. PMID 30476250 DOI: 10.1093/Infdis/Jiy455  0.481
2018 Cross RW, Fenton KA, Geisbert TW. Small animal models of filovirus disease: recent advances and future directions. Expert Opinion On Drug Discovery. 1-14. PMID 30269599 DOI: 10.1080/17460441.2018.1527827  0.425
2018 Gilchuk P, Mire CE, Geisbert JB, Agans KN, Deer DJ, Cross RW, Slaughter JC, Flyak AI, Mani J, Pauly MH, Velasco J, Whaley KJ, Zeitlin L, Geisbert TW, Crowe JE. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates. The Journal of Infectious Diseases. PMID 29982718 DOI: 10.1093/Infdis/Jiy295  0.54
2018 Cross RW, Mire CE, Agans KN, Borisevich V, Fenton KA, Geisbert TW. Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo). The Journal of Infectious Diseases. PMID 29955887 DOI: 10.1093/Infdis/Jiy268  0.428
2018 Warfield KL, Howell KA, Vu H, Geisbert J, Wong G, Shulenin S, Sproule S, Holtsberg FW, Leung DW, Amarasinghe GK, Swenson DL, Bavari S, Kobinger GP, Geisbert TW, Aman MJ. Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms. The Journal of Infectious Diseases. PMID 29939318 DOI: 10.1093/Infdis/Jiy316  0.484
2018 Woolsey C, Geisbert JB, Matassov D, Agans KN, Borisevich V, Cross RW, Deer DJ, Fenton KA, Eldridge JH, Mire CE, Geisbert TW. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates. The Journal of Infectious Diseases. PMID 29939296 DOI: 10.1093/Infdis/Jiy293  0.479
2018 Cross RW, Mire CE, Feldmann H, Geisbert TW. Post-exposure treatments for Ebola and Marburg virus infections. Nature Reviews. Drug Discovery. PMID 29725132 DOI: 10.1038/Nrd.2018.73  0.454
2018 Boisen ML, Hartnett JN, Shaffer JG, Goba A, Momoh M, Sandi JD, Fullah M, Nelson DKS, Bush DJ, Rowland MM, Heinrich ML, Koval AP, Cross RW, Barnes KG, Lachenauer AE, ... ... Geisbert TW, et al. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. Scientific Reports. 8: 5939. PMID 29651117 DOI: 10.1038/S41598-018-24246-W  0.412
2018 Callendret B, Vellinga J, Wunderlich K, Rodriguez A, Steigerwald R, Dirmeier U, Cheminay C, Volkmann A, Brasel T, Carrion R, Giavedoni LD, Patterson JL, Mire CE, Geisbert TW, Hooper JW, et al. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. Plos One. 13: e0192312. PMID 29462200 DOI: 10.1371/Journal.Pone.0192312  0.479
2018 Cross RW, Mire CE, Feldmann H, Geisbert TW. Post-exposure treatments for Ebola and Marburg virus infections. Nature Reviews. Drug Discovery. PMID 29375139 DOI: 10.1038/Nrd.2017.251  0.538
2018 Becker S, Feldmann H, Geisbert T, Kawaoka Y. Marburg and Ebola Viruses – Marking 50 Years Since Their Discovery The Journal of Infectious Diseases. 218: Si-Si. DOI: 10.1093/Infdis/Jiy674  0.348
2017 Matassov D, Mire CE, Latham T, Geisbert JB, Xu R, Ota-Setlik A, Agans KN, Kobs DJ, Wendling MQS, Burnaugh A, Rudge TL, Sabourin CL, Egan MA, Clarke DK, Geisbert TW, et al. Single Dose Trivalent Vesiculovax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge. Journal of Virology. PMID 29142131 DOI: 10.1128/Jvi.01190-17  0.43
2017 Menicucci AR, Versteeg K, Woolsey C, Mire CE, Geisbert JB, Cross RW, Agans KN, Jankeel A, Geisbert TW, Messaoudi I. Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis. Frontiers in Immunology. 8: 1372. PMID 29123522 DOI: 10.3389/Fimmu.2017.01372  0.467
2017 Thi EP, Mire CE, Lee AC, Geisbert JB, Ursic-Bedoya R, Agans KN, Robbins M, Deer DJ, Cross RW, Kondratowicz AS, Fenton KA, MacLachlan I, Geisbert TW. siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease. The Journal of Clinical Investigation. PMID 29106386 DOI: 10.1172/Jci96185  0.49
2017 Mire CE, Cross RW, Geisbert JB, Borisevich V, Agans KN, Deer DJ, Heinrich ML, Rowland MM, Goba A, Momoh M, Boisen ML, Grant DS, Fullah M, Khan SH, Fenton KA, ... ... Geisbert TW, et al. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever. Nature Medicine. PMID 28869611 DOI: 10.1038/Nm.4396  0.407
2017 Versteeg K, Menicucci AR, Woolsey C, Mire CE, Geisbert JB, Cross RW, Agans KN, Jeske D, Messaoudi I, Geisbert TW. Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants. Scientific Reports. 7: 9730. PMID 28852031 DOI: 10.1038/S41598-017-09963-Y  0.404
2017 Mire CE, Geisbert TW. Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop. Trends in Molecular Medicine. PMID 28697885 DOI: 10.1016/J.Molmed.2017.06.008  0.431
2017 Daaboul GG, Freedman DS, Scherr SM, Carter E, Rosca A, Bernstein D, Mire CE, Agans KN, Hoenen T, Geisbert TW, Ünlü MS, Connor JH. Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses. Plos One. 12: e0179728. PMID 28651016 DOI: 10.1371/Journal.Pone.0179728  0.38
2017 Mire CE, Geisbert TW. Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate Models. Methods in Molecular Biology (Clifton, N.J.). 1628: 293-307. PMID 28573630 DOI: 10.1007/978-1-4939-7116-9_24  0.41
2017 Mire CE, Geisbert JB, Borisevich V, Fenton KA, Agans KN, Flyak AI, Deer DJ, Steinkellner H, Bohorov O, Bohorova N, Goodman C, Hiatt A, Kim DH, Pauly MH, Velasco J, ... ... Geisbert TW, et al. Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Science Translational Medicine. 9. PMID 28381540 DOI: 10.1126/Scitranslmed.Aai8711  0.569
2017 Scherr SM, Freedman DS, Agans KN, Rosca A, Carter E, Kuroda M, Fawcett HE, Mire CE, Geisbert TW, Ünlü MS, Connor JH. Disposable cartridge platform for rapid detection of viral hemorrhagic fever viruses. Lab On a Chip. PMID 28194457 DOI: 10.1039/C6Lc01528J  0.393
2017 Geisbert TW. Persistence of Ebola virus RNA in seminal fluid. The Lancet. Global Health. 5: e12-e13. PMID 27955770 DOI: 10.1016/S2214-109X(16)30336-9  0.393
2017 Muñoz-Fontela C, Geisbert TW. The gap between animal and human Ebola virus disease Future Virology. 12: 61-65. DOI: 10.2217/Fvl-2016-0128  0.476
2016 Geisbert TW. First Ebola virus vaccine to protect human beings? Lancet (London, England). PMID 28017402 DOI: 10.1016/S0140-6736(16)32618-6  0.49
2016 Warfield KL, Warren TK, Qiu X, Wells J, Mire CE, Geisbert JB, Stuthman KS, Garza NL, Van Tongeren SA, Shurtleff AC, Agans KN, Wong G, Callahan MV, Geisbert TW, Klose B, et al. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo. Antiviral Research. PMID 27908828 DOI: 10.1016/J.Antiviral.2016.11.019  0.451
2016 Thi EP, Lee AC, Geisbert JB, Ursic-Bedoya R, Agans KN, Robbins M, Deer DJ, Fenton KA, Kondratowicz AS, MacLachlan I, Geisbert TW, Mire CE. Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA. Nature Microbiology. 1: 16142. PMID 27670117 DOI: 10.1038/Nmicrobiol.2016.142  0.434
2016 Benzine JW, Brown KM, Agans KN, Godiska R, Mire CE, Gowda K, Converse B, Geisbert TW, Mead DA, Chander Y. Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood. The Journal of Infectious Diseases. PMID 27638947 DOI: 10.1093/Infdis/Jiw330  0.323
2016 Cross RW, Boisen ML, Millett MM, Nelson DS, Oottamasathien D, Hartnett JN, Jones AB, Goba A, Momoh M, Fullah M, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Brown BL, ... ... Geisbert TW, et al. Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. The Journal of Infectious Diseases. PMID 27587634 DOI: 10.1093/Infdis/Jiw293  0.488
2016 Mire CE, Geisbert JB, Agans KN, Thi EP, Lee AC, Fenton KA, Geisbert TW. Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates. The Journal of Infectious Diseases. PMID 27571900 DOI: 10.1093/Infdis/Jiw333  0.438
2016 Cross RW, Mire CE, Branco LM, Geisbert JB, Rowland MM, Heinrich ML, Goba A, Momoh M, Grant DS, Fullah M, Khan SH, Robinson JE, Geisbert TW, Garry RF. Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. Antiviral Research. PMID 27531367 DOI: 10.1016/J.Antiviral.2016.08.012  0.469
2016 Boisen ML, Cross RW, Hartnett JN, Goba A, Momoh M, Fullah M, Gbakie M, Safa S, Fonnie M, Baimba F, Koroma VJ, Geisbert JB, McCormick S, Nelson DK, Millett MM, ... ... Geisbert TW, et al. Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. The Journal of Infectious Diseases. PMID 27521365 DOI: 10.1093/infdis/jiw261  0.326
2016 Mire CE, Satterfield BA, Geisbert JB, Agans KN, Borisevich V, Yan L, Chan YP, Cross RW, Fenton KA, Broder CC, Geisbert TW. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy. Scientific Reports. 6: 30916. PMID 27484128 DOI: 10.1038/Srep30916  0.482
2016 Goba A, Khan SH, Fonnie M, Fullah M, Moigboi A, Kovoma A, Sinnah V, Yoko N, Rogers H, Safai S, Momoh M, Koroma V, Kamara FK, Konowu E, Yillah M, ... ... Geisbert TW, et al. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. The Journal of Infectious Diseases. PMID 27402779 DOI: 10.1093/Infdis/Jiw239  0.455
2016 Cross RW, Mire CE, Borisevich V, Geisbert JB, Fenton KA, Geisbert TW. The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus. The Journal of Infectious Diseases. PMID 27354371 DOI: 10.1093/Infdis/Jiw209  0.401
2016 Shabman RS, Shrivastava S, Tsibane T, Attie O, Jayaprakash A, Mire CE, Dilley KE, Puri V, Stockwell TB, Geisbert TW, Sachidanandam R, Basler CF. Isolation and Characterization of a Novel Gammaherpesvirus from a Microbat Cell Line. Msphere. 1. PMID 27303702 DOI: 10.1128/mSphere.00070-15  0.342
2016 Mire CE, Geisbert JB, Agans KN, Deer DJ, Fenton KA, Geisbert TW. Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus. The Journal of Infectious Diseases. PMID 27284090 DOI: 10.1093/Infdis/Jiw149  0.419
2016 Robinson JE, Hastie KM, Cross RW, Yenni RE, Elliott DH, Rouelle JA, Kannadka CB, Smira AA, Garry CE, Bradley BT, Yu H, Shaffer JG, Boisen ML, Hartnett JN, Zandonatti MA, ... ... Geisbert TW, et al. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nature Communications. 7: 11544. PMID 27161536 DOI: 10.1038/Ncomms11544  0.421
2016 Satterfield BA, Cross RW, Fenton KA, Borisevich V, Agans KN, Deer DJ, Graber J, Basler CF, Geisbert TW, Mire CE. The Nipah virus C and W proteins contribute to respiratory disease in ferrets. Journal of Virology. PMID 27147733 DOI: 10.1128/Jvi.00215-16  0.401
2016 Mire CE, Geisbert TW, Feldmann H, Marzi A. Ebola Virus Vaccines - reality or fiction? Expert Review of Vaccines. PMID 27078187 DOI: 10.1080/14760584.2016.1178068  0.488
2016 Whitt MA, Geisbert TW, Mire CE. Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses. Methods in Molecular Biology (Clifton, N.J.). 1403: 295-311. PMID 27076138 DOI: 10.1007/978-1-4939-3387-7_16  0.526
2016 Zeitlin L, Geisbert JB, Deer DJ, Fenton KA, Bohorov O, Bohorova N, Goodman C, Kim D, Hiatt A, Pauly MH, Velasco J, Whaley KJ, Altmann F, Gruber C, Steinkellner H, ... ... Geisbert TW, et al. Monoclonal antibody therapy for Junin virus infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 27044104 DOI: 10.1073/Pnas.1600996113  0.43
2016 Edwards MR, Liu G, Mire CE, Sureshchandra S, Luthra P, Yen B, Shabman RS, Leung DW, Messaoudi I, Geisbert TW, Amarasinghe GK, Basler CF. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins. Cell Reports. PMID 26876165 DOI: 10.1016/J.Celrep.2016.01.049  0.418
2016 Pécheur EI, Borisevich V, Halfmann P, Morrey JD, Smee DF, Prichard M, Mire CE, Kawaoka Y, Geisbert TW, Polyak SJ. The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses. Journal of Virology. PMID 26739045 DOI: 10.1128/Jvi.02077-15  0.53
2016 Satterfield BA, Geisbert TW, Mire CE. Inhibition of the host antiviral response by Nipah virus: Current understanding and future perspectives Future Virology. 11: 331-344. DOI: 10.2217/Fvl-2016-0027  0.456
2015 Pattabhi S, Wilkins CR, Dong R, Knoll ML, Posakony J, Kaiser S, Mire CE, Wang ML, Ireton RC, Geisbert TW, Bedard KM, Iadonato SP, Loo YM, Gale M. Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway. Journal of Virology. PMID 26676770 DOI: 10.1128/Jvi.02202-15  0.529
2015 Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, Geisbert J, Saturday G, Komeno T, Geisbert TW, Feldmann H, Gowen BB. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Scientific Reports. 5: 14775. PMID 26456301 DOI: 10.1038/Srep14775  0.567
2015 Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Hartnett JN, Rowland MM, Heinrich ML, Akdag M, Goba A, Momoh M, ... ... Geisbert TW, et al. Development of Prototype Filovirus Recombinant Antigen Immunoassays. The Journal of Infectious Diseases. 212: S359-67. PMID 26232440 DOI: 10.1093/Infdis/Jiv353  0.425
2015 Meyer M, Garron T, Lubaki NM, Mire CE, Fenton KA, Klages C, Olinger GG, Geisbert TW, Collins PL, Bukreyev A. Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses. The Journal of Clinical Investigation. 125: 3241-55. PMID 26168222 DOI: 10.1172/Jci81532  0.42
2015 Matassov D, Marzi A, Latham T, Xu R, Ota-Setlik A, Feldmann F, Geisbert JB, Mire CE, Hamm S, Nowak B, Egan MA, Geisbert TW, Eldridge JH, Feldmann H, Clarke DK. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus. The Journal of Infectious Diseases. 212: S443-51. PMID 26109675 DOI: 10.1093/Infdis/Jiv316  0.529
2015 Satterfield BA, Cross RW, Fenton KA, Agans KN, Basler CF, Geisbert TW, Mire CE. The immunomodulating V and W proteins of Nipah virus determine disease course. Nature Communications. 6: 7483. PMID 26105519 DOI: 10.1038/Ncomms8483  0.428
2015 Cross RW, Fenton KA, Geisbert JB, Ebihara H, Mire CE, Geisbert TW. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model. The Journal of Infectious Diseases. 212: S258-70. PMID 26092858 DOI: 10.1093/Infdis/Jiv182  0.332
2015 Geisbert TW, Strong JE, Feldmann H. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection. The Journal of Infectious Diseases. PMID 26063223 DOI: 10.1093/Infdis/Jiv284  0.584
2015 Cross RW, Fenton KA, Geisbert JB, Mire CE, Geisbert TW. Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig. The Journal of Infectious Diseases. 212: S305-15. PMID 26038397 DOI: 10.1093/Infdis/Jiv237  0.447
2015 Marzi A, Kercher L, Marceau J, York A, Callsion J, Gardner DJ, Geisbert TW, Feldmann H. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines. The Journal of Infectious Diseases. 212: S404-9. PMID 26022440 DOI: 10.1093/Infdis/Jiv188  0.467
2015 Mire CE, Geisbert JB, Versteeg KM, Mamaeva N, Agans KN, Geisbert TW, Connor JH. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs. The Journal of Infectious Diseases. 212: S384-8. PMID 25957964 DOI: 10.1093/Infdis/Jiv126  0.479
2015 Thi EP, Mire CE, Lee AC, Geisbert JB, Zhou JZ, Agans KN, Snead NM, Deer DJ, Barnard TR, Fenton KA, MacLachlan I, Geisbert TW. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature. 521: 362-5. PMID 25901685 DOI: 10.1038/Nature14442  0.506
2015 Safronetz D, Mire C, Rosenke K, Feldmann F, Haddock E, Geisbert T, Feldmann H. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. Plos Neglected Tropical Diseases. 9: e0003736. PMID 25884628 DOI: 10.1371/Journal.Pntd.0003736  0.493
2015 Mire CE, Matassov D, Geisbert JB, Latham TE, Agans KN, Xu R, Ota-Setlik A, Egan MA, Fenton KA, Clarke DK, Eldridge JH, Geisbert TW. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus. Nature. 520: 688-91. PMID 25853476 DOI: 10.1038/Nature14428  0.433
2015 Paweska JT, Jansen van Vuren P, Fenton KA, Graves K, Grobbelaar AA, Moolla N, Leman P, Weyer J, Storm N, McCulloch SD, Scott TP, Markotter W, Odendaal L, Clift SJ, Geisbert TW, et al. Lack of Marburg Virus Transmission From Experimentally Infected to Susceptible In-Contact Egyptian Fruit Bats. The Journal of Infectious Diseases. PMID 25838270 DOI: 10.1093/Infdis/Jiv132  0.506
2015 de Wit E, Marzi A, Bushmaker T, Brining D, Scott D, Richt JA, Geisbert TW, Feldmann H. Safety of recombinant VSV-Ebola virus vaccine vector in pigs. Emerging Infectious Diseases. 21: 702-4. PMID 25811738 DOI: 10.3201/Eid2104.142012  0.511
2015 Geisbert TW. Emergency treatment for exposure to Ebola virus: the need to fast-track promising vaccines. Jama. 313: 1221-2. PMID 25742306 DOI: 10.1001/Jama.2015.2057  0.518
2015 Marzi A, Feldmann F, Geisbert TW, Feldmann H, Safronetz D. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses. Emerging Infectious Diseases. 21: 305-7. PMID 25625358 DOI: 10.3201/Eid2102.141649  0.458
2015 Boisen ML, Schieffelin JS, Goba A, Oottamasathien D, Jones AB, Shaffer JG, Hastie KM, Hartnett JN, Momoh M, Fullah M, Gabiki M, Safa S, Zandonatti M, Fusco M, Bornholdt Z, ... ... Geisbert TW, et al. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. Viral Immunology. 28: 19-31. PMID 25531344 DOI: 10.1089/Vim.2014.0108  0.502
2015 Hartnett JN, Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS, Muncy IJ, Goba A, Momoh M, Fullah M, Mire CE, Geisbert JB, Geisbert TW, Holton DL, Rouelle JA, et al. Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever Future Virology. 10: 559-584. DOI: 10.2217/Fvl.15.41  0.411
2014 Shabman RS, Jabado OJ, Mire CE, Stockwell TB, Edwards M, Mahajan M, Geisbert TW, Basler CF. Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells. Mbio. 5: e02011. PMID 25370495 DOI: 10.1128/Mbio.02011-14  0.352
2014 Geisbert TW. Medical research: Ebola therapy protects severely ill monkeys. Nature. 514: 41-3. PMID 25171470 DOI: 10.1038/Nature13746  0.438
2014 Thi EP, Mire CE, Ursic-Bedoya R, Geisbert JB, Lee AC, Agans KN, Robbins M, Deer DJ, Fenton KA, MacLachlan I, Geisbert TW. Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA. Science Translational Medicine. 6: 250ra116. PMID 25143366 DOI: 10.1126/Scitranslmed.3009706  0.538
2014 Garamszegi S, Yen JY, Honko AN, Geisbert JB, Rubins KH, Geisbert TW, Xia Y, Hensley LE, Connor JH. Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus. Plos Neglected Tropical Diseases. 8: e3061. PMID 25079789 DOI: 10.1371/Journal.Pntd.0003061  0.489
2014 Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Science Translational Medicine. 6: 242ra82. PMID 24964990 DOI: 10.1126/Scitranslmed.3008929  0.556
2014 Mire CE, Geisbert JB, Agans KN, Satterfield BA, Versteeg KM, Fritz EA, Feldmann H, Hensley LE, Geisbert TW. Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates. Plos One. 9: e94355. PMID 24759889 DOI: 10.1371/Journal.Pone.0094355  0.499
2014 Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, Levy DC, Yenni RE, Moses LM, Fullah M, Momoh M, Fonnie M, Fonnie R, Kanneh L, Koroma VJ, ... ... Geisbert TW, et al. Lassa fever in post-conflict sierra leone. Plos Neglected Tropical Diseases. 8: e2748. PMID 24651047 DOI: 10.1371/Journal.Pntd.0002748  0.345
2014 Edwards MR, Johnson B, Mire CE, Xu W, Shabman RS, Speller LN, Leung DW, Geisbert TW, Amarasinghe GK, Basler CF. The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway. Cell Reports. 6: 1017-25. PMID 24630991 DOI: 10.1016/J.Celrep.2014.01.043  0.356
2014 Mire CE, Geisbert JB, Agans KN, Feng YR, Fenton KA, Bossart KN, Yan L, Chan YP, Broder CC, Geisbert TW. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge. Journal of Virology. 88: 4624-31. PMID 24522928 DOI: 10.1128/Jvi.00005-14  0.511
2014 Ursic-Bedoya R, Mire CE, Robbins M, Geisbert JB, Judge A, MacLachlan I, Geisbert TW. Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA. The Journal of Infectious Diseases. 209: 562-70. PMID 23990568 DOI: 10.1093/Infdis/Jit465  0.498
2014 Mire CE, Geisbert TW. Vaccines and antivirals for filoviruses Biology and Pathogenesis of Rhabdo- and Filoviruses. 587-620. DOI: 10.1142/9789814635349_0022  0.448
2014 Geisbert TW. Marburg and Ebola Hemorrhagic Fevers (Filoviruses) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2: 1995-1999.e1. DOI: 10.1016/B978-1-4557-4801-3.00166-1  0.37
2014 Mire CE, Geisbert TW. Viral-vectored vaccines to control pathogenic filoviruses Novel Technologies For Vaccine Development. 33-60. DOI: 10.1007/978-3-7091-1818-4_2  0.414
2013 Mire CE, Geisbert JB, Marzi A, Agans KN, Feldmann H, Geisbert TW. Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus. Plos Neglected Tropical Diseases. 7: e2600. PMID 24367715 DOI: 10.1371/Journal.Pntd.0002600  0.429
2013 Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virology Journal. 10: 353. PMID 24330654 DOI: 10.1186/1743-422X-10-353  0.563
2013 Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF. Mutual antagonism between the ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome Cell Host and Microbe. 14: 74-84. PMID 23870315 DOI: 10.1016/J.Chom.2013.06.010  0.462
2013 Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang LF. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Research. 100: 8-13. PMID 23838047 DOI: 10.1016/J.Antiviral.2013.06.012  0.604
2013 Safronetz D, Geisbert TW, Feldmann H. Animal models for highly pathogenic emerging viruses. Current Opinion in Virology. 3: 205-9. PMID 23403208 DOI: 10.1016/J.Coviro.2013.01.001  0.52
2013 Marzi A, Engelmann F, Feldmann F, Haberthur K, Shupert WL, Brining D, Scott DP, Geisbert TW, Kawaoka Y, Katze MG, Feldmann H, Messaoudi I. Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America. 110: 1893-8. PMID 23319647 DOI: 10.1073/Pnas.1209591110  0.434
2013 Safronetz D, Strong JE, Feldmann F, Haddock E, Sogoba N, Brining D, Geisbert TW, Scott DP, Feldmann H. A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques. The Journal of Infectious Diseases. 207: 1316-27. PMID 23303805 DOI: 10.1093/Infdis/Jit004  0.438
2013 Smith LM, Hensley LE, Geisbert TW, Johnson J, Stossel A, Honko A, Yen JY, Geisbert J, Paragas J, Fritz E, Olinger G, Young HA, Rubins KH, Karp CL. Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever. The Journal of Infectious Diseases. 208: 310-8. PMID 23255566 DOI: 10.1093/Infdis/Jis921  0.411
2013 Feldmann H, Sanchez A, Geisbert TW. Filoviridae: Marburg and ebola viruses Fields Virology: Sixth Edition. 1.  0.358
2012 Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, Geisbert JB, Feng YR, Chan YP, Hickey AC, Broder CC, Feldmann H, Geisbert TW. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Science Translational Medicine. 4: 146ra107. PMID 22875827 DOI: 10.1126/Scitranslmed.3004241  0.533
2012 Broder CC, Geisbert TW, Xu K, Nikolov DB, Wang LF, Middleton D, Pallister J, Bossart KN. Immunization strategies against henipaviruses. Current Topics in Microbiology and Immunology. 359: 197-223. PMID 22481140 DOI: 10.1007/82_2012_213  0.541
2012 Geisbert TW, Feldmann H, Broder CC. Animal challenge models of henipavirus infection and pathogenesis. Current Topics in Microbiology and Immunology. 359: 153-77. PMID 22476556 DOI: 10.1007/82_2012_208  0.515
2012 Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG, Feldmann H, Hensley LE, Geisbert TW. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. Plos Neglected Tropical Diseases. 6: e1567. PMID 22448291 DOI: 10.1371/Journal.Pntd.0001567  0.467
2011 Marzi A, Feldmann H, Geisbert TW, Falzarano D. Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections. Journal of Bioterrorism & Biodefense. PMID 22288023 DOI: 10.4172/2157-2526.S1-004  0.533
2011 Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, et al. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. Science Translational Medicine. 3: 105ra103. PMID 22013123 DOI: 10.1126/Scitranslmed.3002901  0.565
2011 Günther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST, Ströher U, Artsob H, Peters CJ, Ksiazek TG, Becker S, ter Meulen J, Olschläger S, Schmidt-Chanasit J, Sudeck H, et al. Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. The Journal of Infectious Diseases. 204: S785-90. PMID 21987751 DOI: 10.1093/Infdis/Jir298  0.491
2011 Falzarano D, Feldmann F, Grolla A, Leung A, Ebihara H, Strong JE, Marzi A, Takada A, Jones S, Gren J, Geisbert J, Jones SM, Geisbert TW, Feldmann H. Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus. The Journal of Infectious Diseases. 204: S1082-9. PMID 21987745 DOI: 10.1093/Infdis/Jir350  0.411
2011 Geisbert TW, Feldmann H. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. The Journal of Infectious Diseases. 204: S1075-81. PMID 21987744 DOI: 10.1093/Infdis/Jir349  0.566
2011 Marzi A, Ebihara H, Callison J, Groseth A, Williams KJ, Geisbert TW, Feldmann H. Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. The Journal of Infectious Diseases. 204: S1066-74. PMID 21987743 DOI: 10.1093/Infdis/Jir348  0.481
2011 Yen JY, Garamszegi S, Geisbert JB, Rubins KH, Geisbert TW, Honko A, Xia Y, Connor JH, Hensley LE. Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation. The Journal of Infectious Diseases. 204: S1043-52. PMID 21987740 DOI: 10.1093/Infdis/Jir345  0.449
2011 Hensley LE, Alves DA, Geisbert JB, Fritz EA, Reed C, Larsen T, Geisbert TW. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. The Journal of Infectious Diseases. 204: S1021-31. PMID 21987738 DOI: 10.1093/Infdis/Jir339  0.519
2011 Sullivan NJ, Hensley L, Asiedu C, Geisbert TW, Stanley D, Johnson J, Honko A, Olinger G, Bailey M, Geisbert JB, Reimann KA, Bao S, Rao S, Roederer M, Jahrling PB, et al. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nature Medicine. 17: 1128-31. PMID 21857654 DOI: 10.1038/Nm.2447  0.493
2011 Hensley LE, Smith MA, Geisbert JB, Fritz EA, Daddario-DiCaprio KM, Larsen T, Geisbert TW. Pathogenesis of Lassa fever in cynomolgus macaques. Virology Journal. 8: 205. PMID 21548931 DOI: 10.1186/1743-422X-8-205  0.468
2011 Lopez CA, Daaboul GG, Vedula RS, Ozkumur E, Bergstein DA, Geisbert TW, Fawcett HE, Goldberg BB, Connor JH, Unlü MS. Label-free multiplexed virus detection using spectral reflectance imaging. Biosensors & Bioelectronics. 26: 3432-7. PMID 21342761 DOI: 10.1016/J.Bios.2011.01.019  0.386
2011 Geisbert TW, Bailey M, Hensley L, Asiedu C, Geisbert J, Stanley D, Honko A, Johnson J, Mulangu S, Pau MG, Custers J, Vellinga J, Hendriks J, Jahrling P, Roederer M, et al. Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge. Journal of Virology. 85: 4222-33. PMID 21325402 DOI: 10.1128/Jvi.02407-10  0.349
2011 Falzarano D, Geisbert TW, Feldmann H. Progress in filovirus vaccine development: evaluating the potential for clinical use. Expert Review of Vaccines. 10: 63-77. PMID 21162622 DOI: 10.1586/Erv.10.152  0.507
2011 Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet (London, England). 377: 849-62. PMID 21084112 DOI: 10.1016/S0140-6736(10)60667-8  0.54
2010 Yanik AA, Huang M, Kamohara O, Artar A, Geisbert TW, Connor JH, Altug H. An optofluidic nanoplasmonic biosensor for direct detection of live viruses from biological media. Nano Letters. 10: 4962-9. PMID 21053965 DOI: 10.1021/Nl103025U  0.439
2010 Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov SV, Nichol ST, Palacios G, Peters CJ, Tenorio A, Volchkov VE, Jahrling PB. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Archives of Virology. 155: 2083-103. PMID 21046175 DOI: 10.1007/S00705-010-0814-X  0.477
2010 Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, Long D, Broder CC, Feldmann H, Geisbert TW. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. Journal of Virology. 84: 9831-9. PMID 20660198 DOI: 10.1128/Jvi.01163-10  0.567
2010 Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M, Custers J, Jahrling P, Goudsmit J, Koup R, Sullivan NJ. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. Journal of Virology. 84: 10386-94. PMID 20660192 DOI: 10.1128/Jvi.00594-10  0.417
2010 Geisbert TW, Bausch DG, Feldmann H. Prospects for immunisation against Marburg and Ebola viruses. Reviews in Medical Virology. 20: 344-57. PMID 20658513 DOI: 10.1002/Rmv.661  0.479
2010 Geisbert TW, Hensley LE, Geisbert JB, Leung A, Johnson JC, Grolla A, Feldmann H. Postexposure treatment of Marburg virus infection. Emerging Infectious Diseases. 16: 1119-22. PMID 20587184 DOI: 10.3201/Eid1607.100159  0.529
2010 Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet. 375: 1896-905. PMID 20511019 DOI: 10.1016/S0140-6736(10)60357-1  0.434
2010 Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mattapallil JJ, Geisbert JB, Bossart KN, Broder CC. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. Plos One. 5: e10690. PMID 20502528 DOI: 10.1371/Journal.Pone.0010690  0.543
2010 Smith DR, McCarthy S, Chrovian A, Olinger G, Stossel A, Geisbert TW, Hensley LE, Connor JH. Inhibition of heat-shock protein 90 reduces Ebola virus replication. Antiviral Research. 87: 187-94. PMID 20452380 DOI: 10.1016/J.Antiviral.2010.04.015  0.469
2009 Geisbert TW, Geisbert JB, Leung A, Daddario-DiCaprio KM, Hensley LE, Grolla A, Feldmann H. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus. Journal of Virology. 83: 7296-304. PMID 19386702 DOI: 10.1128/Jvi.00561-09  0.491
2009 Geisbert TW, Feldmann F, Geisbert J, Feldmann H. Responses to Ebola and Marburg virus infections Rna Viruses: Host Gene Responses to Infections. 371-390. DOI: 10.1142/9789812833808_0016  0.421
2008 Geisbert TW, Daddario-Dicaprio KM, Lewis MG, Geisbert JB, Grolla A, Leung A, Paragas J, Matthias L, Smith MA, Jones SM, Hensley LE, Feldmann H, Jahrling PB. Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. Plos Pathogens. 4: e1000225. PMID 19043556 DOI: 10.1371/Journal.Ppat.1000225  0.517
2008 Geisbert TW, Daddario-Dicaprio KM, Geisbert JB, Reed DS, Feldmann F, Grolla A, Ströher U, Fritz EA, Hensley LE, Jones SM, Feldmann H. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine. 26: 6894-900. PMID 18930776 DOI: 10.1016/J.Vaccine.2008.09.082  0.473
2008 Fritz EA, Geisbert JB, Geisbert TW, Hensley LE, Reed DS. Cellular immune response to Marburg virus infection in cynomolgus macaques. Viral Immunology. 21: 355-63. PMID 18788943 DOI: 10.1089/Vim.2008.0023  0.394
2008 Geisbert TW, Daddario-DiCaprio KM, Williams KJ, Geisbert JB, Leung A, Feldmann F, Hensley LE, Feldmann H, Jones SM. Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates. Journal of Virology. 82: 5664-8. PMID 18385248 DOI: 10.1128/Jvi.00456-08  0.52
2007 Jahrling PB, Geisbert JB, Swearengen JR, Larsen T, Geisbert TW. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. The Journal of Infectious Diseases. 196: S400-3. PMID 17940976 DOI: 10.1086/520587  0.48
2007 Hensley LE, Stevens EL, Yan SB, Geisbert JB, Macias WL, Larsen T, Daddario-DiCaprio KM, Cassell GH, Jahrling PB, Geisbert TW. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. The Journal of Infectious Diseases. 196: S390-9. PMID 17940975 DOI: 10.1086/520598  0.356
2007 Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, Young HA, Formenty P, Fritz EA, Larsen T, Hensley LE. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. The Journal of Infectious Diseases. 196: S372-81. PMID 17940973 DOI: 10.1086/520608  0.472
2007 Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y. Epitopes required for antibody-dependent enhancement of Ebola virus infection. The Journal of Infectious Diseases. 196: S347-56. PMID 17940970 DOI: 10.1086/520581  0.43
2007 Larsen T, Stevens EL, Davis KJ, Geisbert JB, Daddario-DiCaprio KM, Jahrling PB, Hensley LE, Geisbert TW. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. The Journal of Infectious Diseases. 196: S323-8. PMID 17940967 DOI: 10.1086/520589  0.506
2007 Ebihara H, Theriault S, Neumann G, Alimonti JB, Geisbert JB, Hensley LE, Groseth A, Jones SM, Geisbert TW, Kawaoka Y, Feldmann H. In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. The Journal of Infectious Diseases. 196: S313-22. PMID 17940966 DOI: 10.1086/520590  0.486
2007 Bradfute SB, Braun DR, Shamblin JD, Geisbert JB, Paragas J, Garrison A, Hensley LE, Geisbert TW. Lymphocyte death in a mouse model of Ebola virus infection. The Journal of Infectious Diseases. 196: S296-304. PMID 17940964 DOI: 10.1086/520602  0.47
2007 Bausch DG, Feldmann H, Geisbert TW, Bray M, Sprecher AG, Boumandouki P, Rollin PE, Roth C. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. The Journal of Infectious Diseases. 196: S136-41. PMID 17940941 DOI: 10.1086/520542  0.392
2007 Rubins KH, Hensley LE, Wahl-Jensen V, Daddario DiCaprio KM, Young HA, Reed DS, Jahrling PB, Brown PO, Relman DA, Geisbert TW. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biology. 8: R174. PMID 17725815 DOI: 10.1186/Gb-2007-8-8-R174  0.457
2007 Palacios G, Quan PL, Jabado OJ, Conlan S, Hirschberg DL, Liu Y, Zhai J, Renwick N, Hui J, Hegyi H, Grolla A, Strong JE, Towner JS, Geisbert TW, Jahrling PB, et al. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerging Infectious Diseases. 13: 73-81. PMID 17370518 DOI: 10.3201/Eid1301.060837  0.341
2007 Bausch DG, Geisbert TW. Development of vaccines for Marburg hemorrhagic fever. Expert Review of Vaccines. 6: 57-74. PMID 17280479 DOI: 10.1586/14760584.6.1.57  0.478
2007 Oswald WB, Geisbert TW, Davis KJ, Geisbert JB, Sullivan NJ, Jahrling PB, Parren PW, Burton DR. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. Plos Pathogens. 3: e9. PMID 17238286 DOI: 10.1371/Journal.Ppat.0030009  0.499
2007 Feldmann H, Jones SM, Daddario-DiCaprio KM, Geisbert JB, Ströher U, Grolla A, Bray M, Fritz EA, Fernando L, Feldmann F, Hensley LE, Geisbert TW. Effective post-exposure treatment of Ebola infection. Plos Pathogens. 3: e2. PMID 17238284 DOI: 10.1371/Journal.Ppat.0030002  0.556
2007 Neumann G, Geisbert TW, Ebihara H, Geisbert JB, Daddario-DiCaprio KM, Feldmann H, Kawaoka Y. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. Journal of Virology. 81: 2995-8. PMID 17229700 DOI: 10.1128/Jvi.02486-06  0.558
2006 Daddario-DiCaprio KM, Geisbert TW, Geisbert JB, Ströher U, Hensley LE, Grolla A, Fritz EA, Feldmann F, Feldmann H, Jones SM. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. Journal of Virology. 80: 9659-66. PMID 16973570 DOI: 10.1128/Jvi.00959-06  0.416
2006 Marty AM, Jahrling PB, Geisbert TW. Viral hemorrhagic fevers. Clinics in Laboratory Medicine. 26: 345-86, viii. PMID 16815457 DOI: 10.1016/J.Cll.2006.05.001  0.486
2006 Palacios G, Briese T, Kapoor V, Jabado O, Liu Z, Venter M, Zhai J, Renwick N, Grolla A, Geisbert TW, Drosten C, Towner J, Ju J, Paweska J, Nichol ST, et al. MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerging Infectious Diseases. 12: 692-5. PMID 16704825 DOI: 10.3201/Eid1204.051515  0.342
2006 Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-DiCaprio K, Fritz EA, Jahrling PB, McClintock K, Phelps JR, Lee AC, Judge A, Jeffs LB, MacLachlan I. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. The Journal of Infectious Diseases. 193: 1650-7. PMID 16703508 DOI: 10.1086/504267  0.708
2006 Sullivan NJ, Geisbert TW, Geisbert JB, Shedlock DJ, Xu L, Lamoreaux L, Custers JH, Popernack PM, Yang ZY, Pau MG, Roederer M, Koup RA, Goudsmit J, Jahrling PB, Nabel GJ. Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. Plos Medicine. 3: e177. PMID 16683867 DOI: 10.1371/Journal.Pmed.0030177  0.534
2006 Daddario-DiCaprio KM, Geisbert TW, Ströher U, Geisbert JB, Grolla A, Fritz EA, Fernando L, Kagan E, Jahrling PB, Hensley LE, Jones SM, Feldmann H. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (London, England). 367: 1399-404. PMID 16650649 DOI: 10.1016/S0140-6736(06)68546-2  0.755
2006 Paragas J, Geisbert TW. Development of treatment strategies to combat Ebola and Marburg viruses. Expert Review of Anti-Infective Therapy. 4: 67-76. PMID 16441210 DOI: 10.1586/14787210.4.1.67  0.513
2005 Hensley LE, Jones SM, Feldmann H, Jahrling PB, Geisbert TW. Ebola and Marburg viruses: pathogenesis and development of countermeasures. Current Molecular Medicine. 5: 761-72. PMID 16375711 DOI: 10.2174/156652405774962344  0.52
2005 Geisbert TW. Emerging viruses: advances and challenges. Current Molecular Medicine. 5: 733-4. PMID 16375708 DOI: 10.2174/156652405774962290  0.384
2005 Druar C, Saini SS, Cossitt MA, Yu F, Qiu X, Geisbert TW, Jones S, Jahrling PB, Stewart DI, Wiersma EJ. Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein. Immunogenetics. 57: 730-8. PMID 16215733 DOI: 10.1007/S00251-005-0047-4  0.311
2005 Feldmann H, Jones SM, Schnittler HJ, Geisbert T. Therapy and prophylaxis of Ebola virus infections. Current Opinion in Investigational Drugs (London, England : 2000). 6: 823-30. PMID 16121689  0.46
2005 Hensley LE, Geisbert TW. The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates. Thrombosis and Haemostasis. 94: 254-61. PMID 16113813 DOI: 10.1160/Th05-03-0153  0.393
2005 Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Ströher U, Fernando L, Daddario KM, Guttieri MC, Mothé BR, Larsen T, Hensley LE, Jahrling PB, et al. Development of a new vaccine for the prevention of Lassa fever. Plos Medicine. 2: e183. PMID 15971954 DOI: 10.1371/Journal.Pmed.0020183  0.375
2005 Jones SM, Feldmann H, Ströher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, Daddario KM, Hensley LE, Jahrling PB, Geisbert TW. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nature Medicine. 11: 786-90. PMID 15937495 DOI: 10.1038/Nm1258  0.451
2005 Bray M, Geisbert TW. Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever International Journal of Biochemistry and Cell Biology. 37: 1560-1566. PMID 15896665 DOI: 10.1016/J.Biocel.2005.02.018  0.508
2005 Geisbert TW, Hensley LE, Curtis KM, Geisbert JB, Daddario KM, Kagan E, Lee ACH, Palmer L, Jeffs L, MacLachlan I. 996. Development of an siRNA Based Therapy for Ebola Virus Infection Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.543  0.711
2004 Geisbert TW, Jahrling PB. Exotic emerging viral diseases: Progress and challenges Nature Medicine. 10: S110-S121. PMID 15577929 DOI: 10.1038/Nm1142  0.463
2004 Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW, Owen A, Leduc JW, Brown PO, Relman DA. The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proceedings of the National Academy of Sciences of the United States of America. 101: 15190-5. PMID 15477590 DOI: 10.1073/Pnas.0405759101  0.424
2004 Geisbert TW, Hensley LE. Ebola virus: New insights into disease aetiopathology and possible therapeutic interventions Expert Reviews in Molecular Medicine. 6. PMID 15383160 DOI: 10.1017/S1462399404008300  0.525
2004 Hensley LE, Fritz LE, Jahrling PB, Karp CL, Huggins JW, Geisbert TW. Interferon-beta 1a and SARS coronavirus replication. Emerging Infectious Diseases. 10: 317-9. PMID 15030704 DOI: 10.3201/Eid1002.030482  0.321
2004 Schoepp RJ, Morin MD, Martinez MJ, Kulesh DA, Hensley L, Geisbert TW, Brady DR, Jahrling PB. Detection and identification of Variola virus in fixed human tissue after prolonged archival storage. Laboratory Investigation; a Journal of Technical Methods and Pathology. 84: 41-8. PMID 14631381 DOI: 10.1038/Labinvest.3700008  0.494
2004 Geisbert TW. Microscopy in the hot zone: From the discovery of Ebola virus to a possible treatment Microscopy and Microanalysis. 10: 234-235. DOI: 10.1017/S1431927604883454  0.448
2003 Geisbert TW, Jahrling PB. Towards a vaccine against Ebola virus Expert Review of Vaccines. 2: 777-789. PMID 14711361 DOI: 10.1586/14760584.2.6.777  0.514
2003 Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas J, Young HA, Fredeking TM, Rote WE, Vlasuk GP. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: A study in rhesus monkeys Lancet. 362: 1953-1958. PMID 14683653 DOI: 10.1016/S0140-6736(03)15012-X  0.504
2003 Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. The Journal of Infectious Diseases. 188: 1618-29. PMID 14639531 DOI: 10.1086/379724  0.678
2003 Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. The American Journal of Pathology. 163: 2371-82. PMID 14633609 DOI: 10.1016/S0002-9440(10)63592-4  0.697
2003 Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. The American Journal of Pathology. 163: 2347-70. PMID 14633608 DOI: 10.1016/S0002-9440(10)63591-2  0.699
2003 Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proceedings of the National Academy of Sciences of the United States of America. 100: 12995-3000. PMID 14569023 DOI: 10.1073/Pnas.1735582100  0.434
2003 Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature. 424: 681-4. PMID 12904795 DOI: 10.1038/Nature01876  0.526
2003 Markotic A, Hensley L, Geisbert T, Spik K, Schmaljohn C. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. Journal of General Virology. 84: 2197-2202. PMID 12867652 DOI: 10.1099/Vir.0.19090-0  0.405
2003 Geisbert TW, Hensley LE, Young HA, Reed D, Davis KJ, Jahrling PB. Pathogenesis of Ebola Virus Infection in Nonhuman Primates Uirusu. 53: 55-55. DOI: 10.2222/Jsv.53.55  0.533
2002 Meissner F, Maruyama T, Frentsch M, Hessell AJ, Rodriguez LL, Geisbert TW, Jahrling PB, Burton DR, Parren PWHI. Detection of antibodies against the four subtypes of ebola virus in Sera from any species using a novel antibody-phage indicator assay Virology. 300: 236-243. PMID 12350354 DOI: 10.1006/Viro.2002.1533  0.469
2002 Bray M, Raymond JL, Geisbert T, Baker RO. 3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice. Antiviral Research. 55: 151-9. PMID 12076759 DOI: 10.1016/S0166-3542(02)00018-9  0.536
2002 Parren PWHI, Geisbert TW, Maruyama T, Jahrling PB, Burton DR. Pre- and postexposure prophylaxis of ebola virus infection in an animal model by passive transfer of a neutralizing human antibody Journal of Virology. 76: 6408-6412. PMID 12021376 DOI: 10.1128/Jvi.76.12.6408-6412.2002  0.524
2002 Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerging Infectious Diseases. 8: 503-7. PMID 11996686 DOI: 10.3201/Eid0805.010284  0.547
2002 Liang MH, Geisbert T, Yao Y, Hinrichs SH, Giam CZ. Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosis. Journal of Virology. 76: 4022-33. PMID 11907241 DOI: 10.1128/Jvi.76.8.4022-4033.2002  0.329
2002 Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. The Journal of Experimental Medicine. 195: 593-602. PMID 11877482 DOI: 10.1084/Jem.20011500  0.501
2002 Geisbert TW, Hensley LE, Geisbert JB, Jahrling PB. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections Virology. 293: 15-19. PMID 11853394 DOI: 10.1006/Viro.2001.1279  0.466
2002 Hensley LE, Young HA, Jahrling PB, Geisbert TW. Proinflammatory response during Ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily Immunology Letters. 80: 169-179. PMID 11803049 DOI: 10.1016/S0165-2478(01)00327-3  0.451
2001 Gibb TR, Bray M, Geisbert TW, Steele KE, Kell WM, Davis KJ, Jaax NK. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. Journal of Comparative Pathology. 125: 233-42. PMID 11798240 DOI: 10.1053/Jcpa.2001.0502  0.487
2001 Zaucha GM, Jahrling PB, Geisbert TW, Swearengen JR, Hensley L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis) Laboratory Investigation. 81: 1581-1600. PMID 11742030 DOI: 10.1038/Labinvest.3780373  0.444
2000 Steele KE, Linn MJ, Schoepp RJ, Komar N, Geisbert TW, Manduca RM, Calle PP, Raphael BL, Clippinger TL, Larsen T, Smith J, Lanciotti RS, Panella NA, McNamara TS. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Veterinary Pathology. 37: 208-24. PMID 10810985 DOI: 10.1354/Vp.37-3-208  0.501
2000 Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Laboratory Investigation; a Journal of Technical Methods and Pathology. 80: 171-86. PMID 10701687 DOI: 10.1038/Labinvest.3780021  0.457
1999 Jahrling PB, Geisbert TW, Geisbert JB, Swearengen JR, Bray M, Jaax NK, Huggins JW, LeDuc JW, Peters CJ. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. The Journal of Infectious Diseases. 179: S224-34. PMID 9988188 DOI: 10.1086/514310  0.473
1999 Connolly BM, Steele KE, Davis KJ, Geisbert TW, Kell WM, Jaax NK, Jahrling PB. Pathogenesis of experimental Ebola virus infection in guinea pigs. The Journal of Infectious Diseases. 179: S203-17. PMID 9988186 DOI: 10.1086/514305  0.514
1999 Rollin PE, Williams RJ, Bressler DS, Pearson S, Cottingham M, Pucak G, Sanchez A, Trappier SG, Peters RL, Greer PW, Zaki S, Demarcus T, Hendricks K, Kelley M, Simpson D, ... Geisbert TW, et al. Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. The Journal of Infectious Diseases. 179: S108-14. PMID 9988173 DOI: 10.1086/514303  0.52
1998 Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever The Journal of Infectious Diseases. 178: 651-661. PMID 9988191 DOI: 10.1086/514292  0.512
1998 Geisbert TW, Jaax NK. Marburg hemorrhagic fever: Report of a case studied by immunohistochemistry and electron microscopy Ultrastructural Pathology. 22: 3-17. PMID 9491211 DOI: 10.3109/01913129809032253  0.485
1998 Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. Erratum: A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever (Journal of Infectious Diseases (September 1998) 178 (651-661)) The Journal of Infectious Diseases. 178. DOI: 10.1086/314475  0.319
1997 Jacobson ER, Adams HP, Geisbert TW, Tucker SJ, Hall BJ, Homer BL. Pulmonary Lesions in Experimental Ophidian Paramyxovirus Pneumonia of Aruba Island Rattlesnakes, Crotalus unicolor Veterinary Pathology. 34: 450-459. PMID 9381656 DOI: 10.1177/030098589703400509  0.43
1997 Davis KJ, Anderson AO, Geisbert TW, Steele KE, Geisbert JB, Vogel P, Connolly BM, Huggins JW, Jahrling PB, Jaax NK. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Archives of Pathology & Laboratory Medicine. 121: 805-19. PMID 9278608  0.443
1996 Jahrling PB, Geisbert TW, Jaax NK, Hanes MA, Ksiazek TG, Peters CJ. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. Archives of Virology. Supplementum. 11: 115-34. PMID 8800793 DOI: 10.1007/978-3-7091-7482-1_11  0.494
1996 Johnson ED, Johnson BK, Silverstein D, Tukei P, Geisbert TW, Sanchez AN, Jahrling PB. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya Archives of Virology, Supplement. 1996: 101-114. PMID 8800792 DOI: 10.1007/978-3-7091-7482-1_10  0.477
1996 Hall WC, Geisbert TW, Huggins JW, Jahrling PB. Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease. The American Journal of Tropical Medicine and Hygiene. 55: 81-8. PMID 8702027 DOI: 10.4269/Ajtmh.1996.55.81  0.455
1996 Mills JN, Barrera Oro JG, Bressler DS, Childs JE, Tesh RB, Smith JF, Enria DA, Geisbert TW, McKee KT, Bowen MD, Peters CJ, Jahrling PB. Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus). The American Journal of Tropical Medicine and Hygiene. 54: 399-404. PMID 8615455 DOI: 10.4269/Ajtmh.1996.54.399  0.44
1995 Geisbert TW, Jahrling PB. Differentiation of filoviruses by electron microscopy Virus Research. 39: 129-150. PMID 8837880 DOI: 10.1016/0168-1702(95)00080-1  0.398
1995 Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, Nagley D, Johnson E, Jaax G, Peters C. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet. 346: 1669-71. PMID 8551825 DOI: 10.1016/S0140-6736(95)92841-3  0.52
1994 Kenyon RH, Niklasson B, Jahrling PB, Geisbert T, Svensson L, Frydén A, Bengtsson M, Foberg U, Peters CJ. Virologic investigation of a case of suspected haemorrhagic fever. Research in Virology. 145: 397-406. PMID 7709077 DOI: 10.1016/S0923-2516(07)80046-X  0.504
1992 Geisbert TW, Jahrling PB, Hanes MA, Zack PM. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States Journal of Comparative Pathology. 106: 137-152. PMID 1597531 DOI: 10.1016/0021-9975(92)90043-T  0.489
1991 Geisbert TW, Rhoderick JB, Jahrling PB. Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy Journal of Clinical Pathology. 44: 521-522. PMID 2066435 DOI: 10.1136/Jcp.44.6.521  0.485
1990 Geisbert TW, Jahrling PB. Use of immunoelectron microscopy to show Ebola virus during the 1989 United States epizootic Journal of Clinical Pathology. 43: 813-816. PMID 2229429 DOI: 10.1136/Jcp.43.10.813  0.473
1990 Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (London, England). 335: 502-5. PMID 1968529 DOI: 10.1016/0140-6736(90)90737-P  0.535
Show low-probability matches.